Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Boston Scientific Corporation (BSX)
Market Closed
15 Oct, 08:00 PM
NYSE
All
(9)
DE
(4)
AT
(1)
IT
(1)
MX
(1)
GB
(1)
US
(1)
NYSE
Primary
LSE
XWBO
XETRA
XMEX
XMUN
XDUS
XFRA
XMIL
$
44.
14
+1.14
+2.6512%
$
62.49B
Market Cap
74.55
P/E Ratio
-
Div Yield
13.58M
Volume
2.01
Eps
$
43
Previous Close
Investors:
TJD
DI
LC
+409
Watching
Watch
Add Transaction
Day Range
43.46
44.43
Year Range
41.39
105.65
Want to track
BSX
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
News
Historical Data
Investors
Boston Scientific Corporation (BSX) Statistics
Valuation metrics
Market Cap
62.49B
Enterprise value
75.6B
Trailing P/E (ttm)
17.23
Forward P/E
17.65
PEG ratio
0.38
Price/Sales (ttm)
3.02
Price/Book (mrq)
2.53
Enterprise Value/Revenue
3.6
Enterprise Value/EBITDA
13.03
Overview
Shares outstanding
1.48B
Float
1.48B
Shares short
26.26M
% Held by insiders
0%
% Held by institutions
0.95%
Average volume (10 days)
16.54M
Average volume (90 days)
20.14M
Price summary
52-Week low
41.39
52-Week high
105.65
Beta
0.7
50-Day moving average
44.96
200-Day moving average
51.86
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
2:1
Last split Date
6 Nov 2003
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.17%
Operating margin
0.21%
Operational effectiveness
Return on assets
0.08%
Return on equity
0.15%
Income Statement
Revenue (ttm)
20.07B
Revenue per share (ttm)
14.21
Quarterly revenue growth (yoy)
0.16%
Gross profit (ttm)
13.81B
EBITDA
5.33B
Net income to common (ttm)
2.9B
Diluted EPS (ttm)
2.48
Quarterly earnings growth (yoy)
0.19%
Balance Sheet
Total cash (mrq)
1.96B
Total cash per share (mrq)
0.36
Total debt (mrq)
11.97B
Total Debt/Equity (mrq)
0.51
Current ratio (mrq)
1.24%
Book value per share (mrq)
17.04
Cash Flow
Cash flow statement
4.53B
Levered free cash flow (LFCF)
3.24B